| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.03 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.084 | 0.04 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |